Table 2 ᅟ
Total number of medicines for CVDs | Thiazide diuretics | Selective β1 blockers | Dihydropyridine CCBs | RAAS inhibitors## | Statins | ADP receptor inhibitors## | Thrombolytic agents | Long-acting nitrates | Non-dihydropyridine CCBs## | Heparin-like medicines | Loop diuretics | Aldosterone antagonists | Digitalis glycosides | Oral anticoagulants | Pharmacological cardioversion | Medicines for maintaining sinus rhythm | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Overall | 24 (16-50) | 1 (0-2) | 1 (1-5) | 2 (1-4) | 2(1-11) | 1(0-4) | 0(0-2) | 1(0-2) | 1(0-2) | 1(0-3) | 1(1-4) | 1(1-2) | 1(1-1) | 1(1-2) | 1(0-2) | 1(0-3) | 1(0-4) |
Low income(n = 6) | 19.5(16-24) | 1(1-2) | 1(1-2) | 2(1-3) | 2(1-2) | 0.5(0-2) | 0(0-0) | 0.5(0-2) | 1(0-1) | 1(0-1) | 1(1-2) | 1(1-2) | 1(1-1) | 1(1-2) | 1(0-2) | 0.5(0-1) | 0.5(0-1) |
Lower middle income (n = 11) | 20(16-44) | 1(1-2) | 1(1-3) | 2(1-3) | 2(1-6) | 1(0-4) | 0(0-2) | 1(0-2) | 1(1-2) | 1(1-2) | 1(1-4) | 1(1-2) | 1(1-1) | 1(1-1) | 1(1-2) | 1(0-3) | 1(0-4) |
Upper middle income (n = 17) | 25(17-50) | 1(0-2) | 2(1-5) | 2(1-4) | 2(1-11) | 1(0-4) | 1(0-2) | 1(0-2) | 1(1-2) | 2(0-3) | 2(1-3) | 1(1-2) | 1(1-1) | 1(1-2) | 1(0-2) | 1(0-3) | 1(0-3) |
p-value* | 0.014 | 0.258 | 0.167 | 0.824 | 0.080 | 0.194 | 0.087 | 0.547 | 0.013 | 0.001 | 0.542 | 0.901 | 1.000 | 0.133 | 0.701 | 0.052 | 0.043 |
AMRO₸(n = 9) | 32(20-39) | 1(0-2) | 2(1-3) | 2(1-4) | 3(2-7) | 2(1-4) | 1(0-1) | 1(0-2) | 2(1-2) | 2(1-3) | 2(1-4) | 1(1-1) | 1(1-1) | 1(1-2) | 1(1-2) | 1(1-3) | 1(1-3) |
AFRO(n = 9) | 20(16-44) | 1(0-2) | 1(1-3) | 2(1-3) | 2(1-6) | 0(0-4) | 0(0-2) | 1(0-2) | 1(0-1) | 1(0-2) | 1(1-2) | 1(1-2) | 1(1-1) | 1(1-2) | 1(1-2) | 1(0-3) | 1(0-4) |
WPRO(n = 7) | 21(16-26) | 1(1-2) | 1(1-3) | 1(1-2) | 2(2-2) | 1(0-1) | 0(0-1) | 1(0-1) | 1(1-2) | 1(0-3) | 1(1-2) | 1(1-1) | 1(1-1) | 1(1-2) | 1(0-1) | 1(0-2) | 1(0-2) |
SEARO(n = 5) | 27(20-35) | 1(1-2) | 2(1-3) | 2(1-2) | 2(1-3) | 1(1-1) | 1(1-2) | 1.5(1-2) | 1.5(1-2) | 1.5(1-2) | 2(2-3) | 1(1-1) | 1(1-1) | 1(1-1) | 1(1-1) | 1(1-3) | 1(1-3) |
EMRO(n = 4) | 22(18-50) | 1(1-1) | 2(1-5) | 2.5(1-4) | 3(1-11) | 1(1-4) | 0(0-2) | 1(0-2) | 1(1-1) | 1(1-2) | 2(1-3) | 1(1-2) | 1(1-1) | 1(1-1) | 1(0-1) | 0.5(0-3) | 0.5(0-3) |
p-value** | 0.049 | 0.833 | 0.204 | 0.205 | 0.013 | 0.033 | 0.059 | 0.255 | 0.011 | 0.379 | 0.029 | 0.138 | 1.000 | 0.746 | 0.118 | 0.241 | 0.192 |
WHO # | 21 | 1$ | 1$ | 1$ | 1$ | 1$ | 1 | 1 | 1$ | 1 | 2$ | 1 | 1 | 1 | 1$ | 1 | 1 |